Multiple Sclerosis Treatment
Researchers have not investigated any definite treatment that can prove 100% cure of MS. There are some treatments, which can be helpful to placid one's life with Multiple Sclerosis. The treatment depends upon the severity of MS symptoms and the stage in which the treatment is performed.
As there is no unique treatment or therapy for all types of MS patients, there are some risk factors in treating MS. The medications can cause some life-threatening side effects due to the varied remissions. However, MRI graphs are proving useful to define new therapies or the MS treatment.
Initial Treatment
Initial treatments have been very effective at the early stage of multiple sclerosis. Specialists' experience shows that patients who have diagnosed MS earlier feel good results from the initial treatments. This initial treatment is results better than the treatments administered delayed. Some of the major damages to the nervous system occur at the early stages of MS, so early treatment prevents these damages.
Disease Modifying Treatments
There are different treatments or therapies for different types of patients who have various symptoms and remissions unique. For example, patients with relapsing remissions, remitting subtypes, patients with demyelinating, etc. have been treated with different treatments. Hence, treatments are used to reduce the severity of the attacks and relapses. These treatments are the Disease Modifying Treatments that include following medications:
Interferons
This is the most promising antiviral protein in MS research. It works as the naturally produced interferon by the body while responding to the disease. There are three types of interferons-alpha, beta and gamma. All interferons play a significant role in preventing viral infections. The two betaserons, beta-1b and Avonex (beta-1a) have been approved by the FDA for treatment of MS relapsing-remitting.
- Betaseron (beta-1b): Patients who have consistent features of MS and have gone the first test are given Betasron (beta-1b). It is used to ease the clinical relapses of these patients.
- Rebif (beta-1a): This also reduces the relapsing frequency of Multiple sclerosis and prevents the physical damage of the brain. Rebif have been marketed in Europe for MS treatment.
- Avonex: It helps to slow down the physical disability level of the patients with multiple sclerosis who are experiencing the relapsing forms.
The researchers have seen that beta inferno is effective, as it recovers the deficiency in white blood cells caused by multiple sclerosis. The affected WBC restrains the immune system from being active. The existence of gamma interferon, which contributes to the attacks, makes the beta interferon more effective. Moreover, study has been in progress to use alpha interferon in MS treatment.
On the other hand, these interferons also result some side effects after the treatment. Fatigue, chills, fever, depression, injection and sweating are the side effects of interferons.
Scientists are investigating the unique and result-oriented therapies for the MS treatment. Still an approved treatment is not available to prevent the primary progress of MS. Several medications are used to control the relapses, to build antiviral for infections and attacks and to prevent the growth of Multiple sclerosis.
